SG10201700593YA - Nme variant species expression and suppression - Google Patents
Nme variant species expression and suppressionInfo
- Publication number
- SG10201700593YA SG10201700593YA SG10201700593YA SG10201700593YA SG10201700593YA SG 10201700593Y A SG10201700593Y A SG 10201700593YA SG 10201700593Y A SG10201700593Y A SG 10201700593YA SG 10201700593Y A SG10201700593Y A SG 10201700593YA SG 10201700593Y A SG10201700593Y A SG 10201700593YA
- Authority
- SG
- Singapore
- Prior art keywords
- suppression
- variant species
- species expression
- nme
- nme variant
- Prior art date
Links
- 230000001629 suppression Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases [EC 2.]
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Reproductive Health (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Transplantation (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261675292P | 2012-07-24 | 2012-07-24 | |
US201261677442P | 2012-07-30 | 2012-07-30 | |
US201261679021P | 2012-08-02 | 2012-08-02 | |
US201261683155P | 2012-08-14 | 2012-08-14 | |
US201261684654P | 2012-08-17 | 2012-08-17 | |
US201261693712P | 2012-08-27 | 2012-08-27 | |
PCT/US2012/060684 WO2013059373A2 (en) | 2011-10-17 | 2012-10-17 | Media for stem cell proliferation and induction |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201700593YA true SG10201700593YA (en) | 2017-03-30 |
Family
ID=49997968
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201700593YA SG10201700593YA (en) | 2012-07-24 | 2013-07-24 | Nme variant species expression and suppression |
SG11201606118SA SG11201606118SA (en) | 2012-07-24 | 2013-07-24 | Nme variant species expression and suppression |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201606118SA SG11201606118SA (en) | 2012-07-24 | 2013-07-24 | Nme variant species expression and suppression |
Country Status (9)
Country | Link |
---|---|
US (2) | US20150203823A1 (en) |
EP (2) | EP2877586A4 (en) |
JP (3) | JP6546087B2 (en) |
CN (2) | CN111849874A (en) |
AU (2) | AU2013295811A1 (en) |
CA (1) | CA2880010A1 (en) |
IL (1) | IL236901B (en) |
SG (2) | SG10201700593YA (en) |
WO (1) | WO2014018679A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013059373A2 (en) | 2011-10-17 | 2013-04-25 | Minerva Biotechnologies Corporation | Media for stem cell proliferation and induction |
JP6640086B2 (en) * | 2013-08-12 | 2020-02-05 | ミネルバ バイオテクノロジーズ コーポレーション | How to enhance tumor growth |
US20170204196A1 (en) * | 2014-04-07 | 2017-07-20 | Minerva Biotechnologies Corporation | Anti-nme antibody |
CN107660213B (en) | 2015-02-10 | 2023-01-13 | 米纳瓦生物技术公司 | Humanized anti-MUCl antibodies |
CN109081863A (en) * | 2018-08-01 | 2018-12-25 | 西北民族大学 | The isolation and identification method of anti-cancer active matter D actinomycin D FGR |
JP2022519120A (en) | 2019-02-04 | 2022-03-18 | ミネルヴァ バイオテクノロジーズ コーポレーション | Anti-NME antibody and treatment of cancer or cancer metastasis |
JP2023530039A (en) | 2020-06-08 | 2023-07-12 | ミネルバ バイオテクノロジーズ コーポレーション | Anti-NME Antibodies and Methods of Treating Cancer or Cancer Metastasis |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2329822A1 (en) * | 2001-09-05 | 2011-06-08 | Minerva Biotechnologies Corporation | Compositions and methods of treatment of cancer |
EP1375661A1 (en) * | 2002-06-17 | 2004-01-02 | Academisch Ziekenhuis Bij De Universiteit Van Amsterdam | The role of the N-myc - nm23H1/nm23H2 - cdc42 pathway in proliferation, differentiation and treatment of cancer |
CN101273060A (en) * | 2005-06-24 | 2008-09-24 | 美国政府(由卫生和人类服务部、国立卫生研究院的部长所代表) | Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain (PLAD) of tumor necrosis factor receptors |
JP2008099662A (en) * | 2006-09-22 | 2008-05-01 | Institute Of Physical & Chemical Research | Method for culturing stem cell |
WO2008067065A2 (en) * | 2006-10-19 | 2008-06-05 | Shiv Srivastava | Methods, kits, and systems for diagnosing and prognosing prostate cancer using secreted biomarkers |
CN101652469B (en) * | 2006-12-06 | 2014-04-16 | 米纳瓦生物技术公司 | Method for identifying and manipulating cells |
WO2009012173A2 (en) | 2007-07-13 | 2009-01-22 | Dharmacon, Inc. | Enhanced biotherapeutic production using inhibitory rna |
KR20200133324A (en) * | 2008-10-09 | 2020-11-27 | 미네르바 바이오테크놀로지 코포레이션 | Method for inducing pluripotency in cells |
KR20170075023A (en) * | 2009-06-11 | 2017-06-30 | 미네르바 바이오테크놀로지 코포레이션 | Methods for culturing stem and progenitor cells |
CN109112097A (en) * | 2010-06-16 | 2019-01-01 | 米纳瓦生物技术公司 | Reprogram cancer cell |
EP2872636A4 (en) * | 2012-07-13 | 2016-08-17 | Minerva Biotechnologies Corp | Method for inducing cells to less mature state |
-
2013
- 2013-07-24 CN CN202010752407.5A patent/CN111849874A/en active Pending
- 2013-07-24 AU AU2013295811A patent/AU2013295811A1/en not_active Abandoned
- 2013-07-24 EP EP13823099.0A patent/EP2877586A4/en active Pending
- 2013-07-24 JP JP2015524428A patent/JP6546087B2/en active Active
- 2013-07-24 EP EP22198880.1A patent/EP4206318A1/en not_active Withdrawn
- 2013-07-24 CN CN201380049792.5A patent/CN104995518A/en active Pending
- 2013-07-24 WO PCT/US2013/051899 patent/WO2014018679A2/en active Application Filing
- 2013-07-24 CA CA2880010A patent/CA2880010A1/en active Pending
- 2013-07-24 SG SG10201700593YA patent/SG10201700593YA/en unknown
- 2013-07-24 SG SG11201606118SA patent/SG11201606118SA/en unknown
-
2015
- 2015-01-23 US US14/604,579 patent/US20150203823A1/en not_active Abandoned
- 2015-01-25 IL IL236901A patent/IL236901B/en active IP Right Grant
-
2019
- 2019-05-02 AU AU2019203098A patent/AU2019203098B2/en active Active
- 2019-05-13 JP JP2019090368A patent/JP2019141100A/en active Pending
-
2021
- 2021-08-16 JP JP2021132192A patent/JP7386210B2/en active Active
-
2022
- 2022-09-27 US US17/935,854 patent/US20230049461A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
SG11201606118SA (en) | 2016-08-30 |
JP2019141100A (en) | 2019-08-29 |
CN111849874A (en) | 2020-10-30 |
JP2021192614A (en) | 2021-12-23 |
AU2013295811A1 (en) | 2015-03-12 |
JP6546087B2 (en) | 2019-07-17 |
AU2019203098B2 (en) | 2021-04-08 |
WO2014018679A3 (en) | 2015-05-07 |
EP2877586A4 (en) | 2016-02-17 |
US20230049461A1 (en) | 2023-02-16 |
CA2880010A1 (en) | 2014-01-30 |
IL236901A0 (en) | 2015-03-31 |
IL236901B (en) | 2021-03-25 |
JP7386210B2 (en) | 2023-11-24 |
CN104995518A (en) | 2015-10-21 |
US20150203823A1 (en) | 2015-07-23 |
AU2019203098A1 (en) | 2019-05-23 |
EP2877586A2 (en) | 2015-06-03 |
EP4206318A1 (en) | 2023-07-05 |
WO2014018679A2 (en) | 2014-01-30 |
JP2015529454A (en) | 2015-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1223401A1 (en) | Methods and compositions for treatment of a genetic condition | |
HK1220282A1 (en) | Context-sensitive handling of interruptions | |
HK1202545A1 (en) | New diazaspirocycloalkane and azaspirocycloalkane | |
ZA201408594B (en) | Xylitol-based anti-mucosal compositions and related methods and compositions | |
EP2814472A4 (en) | Dithioamine reducing agents | |
GB201223022D0 (en) | Natural language processing | |
IL236901B (en) | Nme variant species expression and suppression | |
EP2806872A4 (en) | Bendamustine compositions and methods therefore | |
HK1203763A1 (en) | Compounds and methods for treating candidiasis and aspergillus infections | |
HK1216250A1 (en) | 8-hydroxy-dihydroergotamine compounds and compositions 8-- | |
GB201216649D0 (en) | Agents and methods | |
ZA201405393B (en) | Aryloxyacetamide compound and pesticide | |
GB201315350D0 (en) | Methods and compositions | |
IL219244A0 (en) | Splitting of user-lists | |
EP2879670A4 (en) | Antibacterial compositions and methods | |
GB201315347D0 (en) | Methods and compositions | |
GB201210398D0 (en) | Crop enhancement | |
GB201319388D0 (en) | Rope protector | |
GB201207907D0 (en) | Treatment of depression | |
GB201213778D0 (en) | Process and dressng | |
GB2506242B (en) | Pillowrap - pillow protector | |
RS56379B1 (en) | Dermo-protective and dermo-balancing composition | |
GB201222736D0 (en) | Composition and process | |
GB201212715D0 (en) | Treatment of fungal infections | |
GB201222541D0 (en) | Kiddibidet and pottibidet |